Wood Stephen J, Berger Gregor E, Lambert Martin, Conus Phillipe, Velakoulis Dennis, Stuart Geoffrey W, Desmond Patricia, McGorry Patrick D, Pantelis Christos
Melbourne Neuropsychiatry Centre, University of Melbourne, c/o National Neuroscience Facility, 161 Barry Street, Carlton, Melbourne, Victoria 3053, Australia.
Arch Gen Psychiatry. 2006 Sep;63(9):969-76. doi: 10.1001/archpsyc.63.9.969.
Recent magnetic resonance imaging studies have attempted to relate volumetric brain measurements in early schizophrenia to clinical and functional outcome some years later. These studies have generally been negative, perhaps because gray and white matter volumes inaccurately assess the underlying dysfunction that might be predictive of outcome.
To investigate the predictive value of frontal and temporal spectroscopy measures for outcome in patients with first-episode psychoses.
Left prefrontal cortex and left mediotemporal lobe voxels were assessed using proton magnetic resonance spectroscopy to provide the ratio of N-acetylaspartate (NAA) and choline-containing compounds to creatine and phosphocreatine (Cr) (NAA/Cr ratio). These data were used to predict outcome at 18 months after admission, as assessed by a systematic medical record audit.
Early psychosis clinic.
Forty-six patients with first-episode psychosis.
We used regression models that included age at imaging and duration of untreated psychosis to predict outcome scores on the Global Assessment of Functioning Scale, Clinical Global Impression scales, and Social and Occupational Functional Assessment Scale, as well as the number of admissions during the treatment period. We then further considered the contributions of premorbid function and baseline level of negative symptoms.
The only spectroscopic predictor of outcome was the NAA/Cr ratio in the prefrontal cortex. Low scores on this variable were related to poorer outcome on all measures. In addition, the frontal NAA/Cr ratio explained 17% to 30% of the variance in outcome.
Prefrontal neuronal dysfunction is an inconsistent feature of early psychosis; rather, it is an early marker of poor prognosis across the first years of illness. The extent to which this can be used to guide treatment and whether it predicts outcome some years after first presentation are questions for further research.
近期的磁共振成像研究试图将早期精神分裂症患者的脑容量测量结果与数年后的临床及功能转归联系起来。这些研究通常未得出肯定结果,可能是因为灰质和白质体积无法准确评估可能预测转归的潜在功能障碍。
探讨额叶和颞叶波谱测量对首发精神病患者转归的预测价值。
采用质子磁共振波谱对左侧前额叶皮质和左侧颞中叶体素进行评估,以得出N - 乙酰天门冬氨酸(NAA)与含胆碱化合物相对于肌酸和磷酸肌酸(Cr)的比率(NAA/Cr比率)。通过系统的病历审核评估入院18个月后的转归情况,利用这些数据进行预测。
早期精神病诊所。
46例首发精神病患者。
我们使用回归模型,纳入成像时的年龄和未治疗精神病的持续时间,以预测功能总体评定量表、临床总体印象量表、社会和职业功能评定量表上的转归分数,以及治疗期间的住院次数。然后我们进一步考虑病前功能和阴性症状基线水平的作用。
唯一可预测转归的波谱指标是前额叶皮质的NAA/Cr比率。该变量得分低与所有测量指标的较差转归相关。此外,额叶NAA/Cr比率解释了转归差异的17%至30%。
前额叶神经元功能障碍并非早期精神病的一致特征;相反,它是疾病最初几年预后不良的早期标志物。这一指标在多大程度上可用于指导治疗以及是否能预测首次发病数年后的转归,有待进一步研究。